LONG-TERM TREATMENT OF PRIMARY PULMONARY HYPERTENSION WITH CONTINUOUS INTRAVENOUS EPOPROSTENOL (PROSTACYCLIN)
Authors:
- 1 May 1984
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 323 (8385) , 1046-1047
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- INTERMITTENT EPOPROSTENOL (PROSTACYCLIN) INFUSION IN PATIENTS WITH RAYNAUD'S SYNDROMEThe Lancet, 1983
- Deleterious Effects of Hydralazine in Patients with Pulmonary HypertensionNew England Journal of Medicine, 1982
- Heart-Lung TransplantationNew England Journal of Medicine, 1982
- Remission of primary pulmonary hypertension during treatment with diazoxide.BMJ, 1981
- PROSTACYCLIN AND PROSTAGLANDIN E1 FOR SEVERE IDIOPATHIC PULMONARY ARTERY HYPERTENSIONThe Lancet, 1980
- Oral Hydralazine Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1980